Bristol-Myers Squibb's Cobenfy launch shows strong initial sales and growth potential. Learn why BMY stock is a solid ...

“KarXT is the first new class of treatment for ... as compared to current antipsychotic medicines, which mostly target dopamine or serotonin receptors. Zai Lab has an exclusive license from ...

With everything from clothes and electronics to diapers and groceries, shopping at Target is as close to one-stop shopping as possible. If you spend much of your budget here, you can benefit from the ...

We would like to share some important news with you. After years of bringing you the latest insights, analysis and innovation news from the pharma industries, we have made the difficult decision to ...

Prime Target kicks off with a fascinating premise: Edward Brooks (Leo Woodall) is on the brink of unraveling the mathematical secrets that safeguard every computer system in the world. The ...

Xanomeline and trospium chloride (KarXT), a novel M1/M4 muscarinic receptor agonist, significantly improves cognitive performance among patients with schizophrenia who have baseline cognitive ...

"In clinical trials, KarXT demonstrated statistically significant reductions of schizophrenia symptoms along with a tolerable safety profile. If approved, KarXT has the potential to redefine the ...